Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 8:39 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 97–120 of 3,925 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: HTN Clear all

Conditions: Hypertension, Diabetes Mellitus
Interventions: aliskiren; Drug
Lead sponsor: Novartis; Industry
Eligibility: 18 Years and older
Enrollment: 839 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2005
U.S. locations: 1
States / cities: East Hanover, New Jersey

Conditions: Medication Non-adherence
Interventions: SMS (Text messages); Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 21 Years and older
Enrollment: 49 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 2
States / cities: Ann Arbor, Michigan • Grand Rapids, Michigan

Conditions: Pregnancy Related, Pre-Eclampsia
Interventions: Modified natural cycle, Programmed cycle; Procedure
Lead sponsor: JHSPH Center for Clinical Trials; Other
Eligibility: 18 Years to 41 Years · Female only
Enrollment: 788 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2026
U.S. locations: 15
States / cities: San Francisco, California • Sunnyvale, California • Orange, Connecticut + 12 more

Conditions: Hypertension, Diabetes, Hypercholesterolemia
Interventions: education intervention; Behavioral
Lead sponsor: Durham VA Medical Center; Federal
Eligibility: 18 Years and older
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Pulmonary Hypertension, Heart Failure With Preserved Ejection Fraction
Interventions: Ambrisentan, Placebo; Drug · Other
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 70 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Stasis Dermatitis
Interventions: crisaborole ointment, vehicle ointment; Drug · Other
Lead sponsor: Pfizer; Industry
Eligibility: 45 Years and older
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 4
States / cities: El Segundo, California • Lafayette, California • South San Francisco, California + 1 more

Conditions: Diabetes Mellitus, Type 2, Hypertension
Interventions: diabetes and hypertension self-management; Behavioral
Lead sponsor: West Virginia University; Other
Eligibility: 18 Years to 90 Years
Enrollment: 74 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Morgantown, West Virginia

Conditions: Atrial Fibrillation, Hypertension
Interventions: AF ablation with Renal Denervation, AF ablation alone; Procedure
Lead sponsor: Siva Mulpuru; Other
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Cognitive Decline, Hypertension, Diet, Aerobic Exercise
Interventions: Enhanced Usual Care (EUC), Food Delivery and Cooking PLUS Aerobic Training (FoRKS+); Behavioral
Lead sponsor: Indiana University; Other
Eligibility: 35 Years to 75 Years
Enrollment: 128 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Cardiovascular Disease
Interventions: Not listed
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: Up to 99 Years
Enrollment: 7,829 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1995 – 2020
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Diabetic Retinopathy, Diabetes Mellitus, Type 2, Glaucoma
Interventions: Behavioral Activation, Supportive Therapy; Behavioral
Lead sponsor: Wills Eye; Other
Eligibility: 21 Years and older
Enrollment: 206 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 3
States / cities: Philadelphia, Pennsylvania

Conditions: Chronic Disease, Cardiovascular Diseases, Hypertension, Diabetes, Pre-diabetes, Obesity
Interventions: Total Health Improvement Program; Behavioral
Lead sponsor: Pacific Northwest University of Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Roseburg, Oregon

Conditions: Obesity, Maternal, Pre-Eclampsia; Complicating Pregnancy, Gestational Hypertension, Eclampsia; Complicating Pregnancy
Interventions: MFeast ENHANCED, MFeast Usual Care; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Cardiovascular Disease, Preeclampsia, Hypertension, Post-partum Weight Retention
Interventions: Web-based educational and motivational modules, Information and Screening Group; Behavioral
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 44 Years · Female only
Enrollment: 151 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Healthy
Interventions: Sodium Nitrite, Sodium Nitrite Injection; Drug
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 21 Years to 60 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2011
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Pulmonary Fibrosis, Pulmonary Hypertension
Interventions: INOpulse®, Placebo, Long Term Follow Up; Combination Product
Lead sponsor: Bellerophon; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 85 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 23
States / cities: Phoenix, Arizona • Los Angeles, California • Sacramento, California + 19 more

Conditions: Hypertension
Interventions: mobile cognitive behavioral stress management intervention, Diploma in Stress Management course; Behavioral
Lead sponsor: ISA Associates, Inc.; Other
Eligibility: 18 Years and older · Male only
Enrollment: 135 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Hypertension
Interventions: Ramipril, Telmisartan; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 55 Years and older
Enrollment: 63,744 participants
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Open Angle Glaucoma (OAG), Ocular Hypertension (OH)
Interventions: Travoprost; Combination Product
Lead sponsor: Glaukos Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Kenosha, Wisconsin

Conditions: Hypertension, Electronic Health Record, Digital Health
Interventions: Connected-device, Usual care; Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 2
States / cities: Portola Valley, California • Santa Clara, California

Conditions: Heart Failure, Pulmonary Hypertension
Interventions: Exercise Training; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Glaucoma, Glaucoma, Open-Angle, Glaucoma; Drugs, Droopy Eyelid, Ptosis, Glaucoma, Primary Open Angle
Interventions: brimonidine tartrate ophthalmic solution 0.025%, sterile balanced saline solution; Drug · Other
Lead sponsor: Tulane University; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2036
U.S. locations: 1
States / cities: New Orleans, Louisiana

Conditions: Primary Open Angle Glaucoma
Interventions: motivational interviewing, three phone calls to remind patients to take their eye drops; Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years and older
Enrollment: 201 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2013
U.S. locations: 2
States / cities: Aurora, Colorado • Portland, Oregon

Conditions: Hypertension
Interventions: Placebo, ALN-AGT01; Drug
Lead sponsor: Alnylam Pharmaceuticals; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 394 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 54
States / cities: Birmingham, Alabama • Tempe, Arizona • Beverly Hills, California + 44 more

Search by objective public record fields.

A Clinical Study to Evaluate the Safety and Efficacy of Aliskiren Alone and in Combination With Ramipril in Hypertensive, Diabetic Patients.

Improving Adherence and Outcomes by Artificial Intelligence-Adapted Text Messages

Natural Versus Programmed Frozen Embryo Transfer (NatPro)

Medication Adherence With Polyglot Meducation

Safety and Efficacy Trial to Treat Diastolic Heart Failure Using Ambrisentan

Study Evaluating Efficacy and Safety of Crisaborole in Adults With Stasis Dermatitis

Diabetes and Hypertension Self Management Program

Renal Denervation Therapy in Hypertensive Patients Undergoing A-Fib Ablation

MIND Foods and Aerobic Training in Black Adults With HTN

Evaluation of Patients With Heart Disease Not Eligible for Research Protocols

Confronting Unequal Eye Care in Pennsylvania

Total Health Improvement Program Research Project

Nutrition Optimization and Community Upliftment for Postpartum Recovery: Hypertension

Heart Health 4 Moms Trial to Reduce CVD Risk After Preeclampsia

Nitrite Infusion in Healthy Volunteers

A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis

Using Mobile Stress Management to Reduce Hypertension in African American Men

Replication of the ONTARGET Antihypertensive Trial in Healthcare Claims Data

Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcg

Virtual Hypertension Management Pilot

Exercise Training to Improve Cardiopulmonary Hemodynamics in Heart Failure Patients

The Effect of Lumify™ on Ocular Redness, Intraocular Pressure, and Eyelid Position in Glaucoma Patients

RESEARCH PROTOCOL: Glaucoma Treatment Adherence and Persistence

A Study to Evaluate Efficacy and Safety of ALN-AGT01 in Patients With Mild To-Moderate Hypertension